Publications by authors named "Anthony Gulati"

Claim this Profile
P
PROSTest, a Novel Liquid Biopsy Molecular Assay, Accurately Guides Prostate Cancer Biopsy Decision-Making in Men with Elevated PSA Irrespective of DRE Findings.
Craig G Rogers, Srinivas V Koduru, Anthony Gulati, Abdel B Halim

Cancers (Basel)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Association of Convalescent Plasma Therapy With Survival in Patients With Hematologic Cancers and COVID-19.
Michael A Thompson, Jeffrey P Henderson, Pankil K Shah, Samuel M Rubinstein, Michael J Joyner, Anthony P Gulati

JAMA Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical impact of COVID-19 on patients with cancer (CCC19): a cohort study.
Nicole M Kuderer, Toni K Choueiri, Dimpy P Shah, Yu Shyr, Samuel M Rubinstein, Anthony P Gulati

Lancet· June 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of NETest Clinical Utility in a U.S. Registry-Based Study.
Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman, William Grosh

Oncologist· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Time for a change and to adopt a novel molecular genomic approach in NETs.
Lisa Bodei, Eric Liu, Scott Paulson, Anthony Gulati, Jon Freudman

Nat Rev Clin Oncol· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High response rates and prolonged survival in patients with corticotroph pituitary tumors and refractory Cushing disease from capecitabine and temozolomide (CAPTEM): a case series.
Brad E Zacharia, Anthony P Gulati, Jeffrey N Bruce, Arthur S Carminucci, Sharon L Wardlaw

Neurosurgery· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of multiple endocrine neoplasia 1/2 tumors: case report and review of the literature.
Anthony P Gulati, Benjamin Krantz, Rebecca A Moss, Wendy N Moyal, Dawn A Tsushima

Oncology· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Capecitabine and temozolomide (CAPTEM) for metastatic, well-differentiated neuroendocrine cancers: The Pancreas Center at Columbia University experience.
Robert L Fine, Anthony P Gulati, Benjamin A Krantz, Rebecca A Moss, Stephen Schreibman

Cancer Chemother Pharmacol· March 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Is there a role for liver transplantation in metastatic pancreatic neuroendocrine tumors (PNET)?
Anthony Paul Gulati, Muhammad Wasif Saif

JOP· May 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Retinal neovascularization and hemorrhage associated with the use of imatinib (Gleevec(®)) in a patient being treated for gastrointestinal stromal tumor (GIST).
Anthony Paul Gulati, Muhammad Wasif Saif

Anticancer Res· April 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The clinical management of BRCA1 and BRCA2 mutation carriers.
Anthony P Gulati, Susan M Domchek

Curr Oncol Rep· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mutant human tumor suppressor p53 modulates the activation of mitogen-activated protein kinase and nuclear factor-kappaB, but not c-Jun N-terminal kinase and activated protein-1.
Anthony P Gulati, Yang-Ming Yang, David Harter, Asok Mukhopadhyay, Bharat B Aggarwal

Mol Carcinog· January 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis